Work

Modulating Acinetobacter baumannii BfmR (RstA) drug target: Daniellia oliveri compounds as RstA quorum sensing inhibitors

Year: 2025
Type: article
Abstract: Plant products have been integral to the derivation of interventive therapies to mitigate the current scourge of antimicrobial resistance (AMR). The South African plant, Daniellia oliveri , may yet hold promise against WHO-listed critical priority pathogens like Acinetobacter baumannii and its quorum sensing (QS) system, BfmR (RstA). Hence, we bio-prospected D. oliveri compounds in a bid to provide alternative antimicrobial therapeutics, specifically, potential quorum sensing inhibitors (QSIs). This study utilized a range of in silico validated tools for the cheminformatic analysis of RstA modulating properties of D. oliveri- associated compounds. The two (2) lead compounds identified (β-carotene, β-amyrin) had docking scores of -6.8 kcal/mol, relative to -6.7 kcal/mol observed for the azithromycin reference. Only cis-Calamenene and β-amyrin had pharmacokinetic features conformed to the rule of 5 (Ro5) for selection as potential oral drug candidates. β-carotene and rutin had the best quantum reactivity attributes (lowest energy gap, and highest electronegativity and global electrophilicity). Molecular dynamics (MD) simulation revealed that all lead ligands bound to RstA stabilized system compactness and thermodynamics. Although the azithromycin-RstA system had the least ∆G bind (-40.48 kcal/mol), rutin had the next highest ∆G bind (-31.53 kcal/mol) of all D. oliveri compounds. Overall, these lead Daniellia oliveri metabolites may yet have potential RstA inhibitory/modulatory action upon further structural modification, and in vitro and in vivo validation tests prior to formulation into oral, interventive QSIs targeting A. baumannii RstA modulation. • Daniellia oliveri lead metabolites possess RstA inhibitory attributes • D. oliveri -based cis-Calamenene, β-amyrin, rutin, β-carotene, reported first time • Rutin, β-carotene had best quorum sensing modulatory activity against RstA • Leads validated in- silico; with key residues (Val113, Arg 124, Thr125) interaction • Lead ligands; stable and compact thermodynamics, with good drug-like properties
Language: English
Open Access status: hybrid
Estimated APC paid: $3,320
OpenAlex ID: W4408076859
FWCI: 1.01
Cites: 51
Cited by: 4
Related to: 10